CoronavirusCovid-19Health

Novavax’s Coronavirus Vaccine in Final Testing Stages

Gaithersburg, Md.-based Novavax is beginning the final stages of testing for its coronavirus vaccine candidate.

Novavax is the fifth company to reach the testing stage after Pfizer/BioNTech, Moderna, Johnson & Johnson and AstraZeneca.

About 30,000 volunteers — preferably from adults who are in the high-risk categories such as the elderly, Blacks, Latinos and those who have been significantly affected by the virus — will be needed for the terminal clinical testing stages, The Associated Press reported.

Two-thirds of the federally-funded Novavax study volunteers will get the vaccine and the others will receive “dummy” shots. The Novavax vaccine candidate uses lab-grown harmless copies of the spike protein that coats the coronavirus to train the body to recognize if the real virus comes along, AP reported.

The U.S. has already given the vaccines from Pfizer/BioNTech and Moderna emergency-use authorization, though neither will be available to the general public for several months.

Dr. Anthony Fauci, the nation’s top infectious disease expert and member of the White House Coronavirus Task Force, said vaccine candidates other than Pfizer’s and Moderna’s will be needed to fully vaccinate the country.

“If you want to have enough vaccine to vaccinate all the people in the U.S. who you’d like to vaccinate — up to 85 percent or more of the population—you’re going to need more than two companies,” Fauci told AP.

As of Monday, the U.S. has roughly 19.2 million coronavirus cases and 334,000 related deaths, both tops globally, according to a Johns Hopkins University tracker.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Yes, I would like to receive emails from Washington Informer Newspaper. Sign me up!


By submitting this form, you are consenting to receive marketing emails from: Washington Informer Newspaper, 3117 Martin Luther King Jr. Ave SE, Washington, DC, 20032, http://www.washingtoninformer.com. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

Back to top button

My News Matters to me - Washington Informer Donations

Be a Part of The Washington Informer Legacy

A donation of your choice empowers our journalists to continue the work to better inform, educate and empower you through technology and resources that you use.

Click Here Today to Support Black Press and be a part of the Legacy!

Subscribe today for free and be the first to have news and information delivered directly to your inbox.


By submitting this form, you are consenting to receive marketing emails from: Washington Informer Newspaper, 3117 Martin Luther King Jr. Ave SE, Washington, DC, 20032, http://www.washingtoninformer.com. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

Adblock Detected

Please consider supporting us by disabling your ad blocker